New chief scientific officer at Alnylam
This article was originally published in Scrip
Executive Summary
The US RNAi therapeutics company Alnylam Pharmaceuticals has named Dr John Schmidt chief scientific officer. He was formerly vice-president and US member of the Sanofi-Aventis global discovery leadership team, where he was also responsible for biotherapeutics, external innovation and discovery initiatives in China.